Myriad Genetics (NASDAQ:MYGN) Lowered to Hold Rating by StockNews.com
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number of other equities analysts have also recently issued reports on MYGN. Scotiabank dropped their target price on Myriad Genetics from $24.00 to […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number of other equities analysts have also recently issued reports on MYGN. Scotiabank dropped their target price on Myriad Genetics from $24.00 to […]
